Early Drug Development - Bringing a Preclinical Candidate to the Clinic (Hardcover)


This one-stop reference systematically covers key aspects in early drug development that are directly relevant to the discovery phase and are required for first-in-human studies. Its broad scope brings together critical knowledge from many disciplines, ranging from process technology to pharmacology to intellectual property issues. After introducing the overall early development workflow, the critical steps of early drug development are described in a sequential and enabling order: the availability of the drug substance and that of the drug product, the prediction of pharmacokinetics and -dynamics, as well as that of drug safety. The final section focuses on intellectual property aspects during early clinical development. The emphasis throughout is on recent case studies to exemplify salient points, resulting in an abundance of practice-oriented information that is usually not available from other sources. Aimed at medicinal chemists in industry as well as academia, this invaluable reference enables readers to understand and navigate the challenges in developing clinical candidate molecules that can be successfully used in phase one clinical trials.

R6,523
List Price R8,253
Save R1,730 21%

Or split into 4x interest-free payments of 25% on orders over R50
Learn more

Discovery Miles65230
Mobicred@R611pm x 12* Mobicred Info
Free Delivery
Delivery AdviceOut of stock

Toggle WishListAdd to wish list
Review this Item

Product Description

This one-stop reference systematically covers key aspects in early drug development that are directly relevant to the discovery phase and are required for first-in-human studies. Its broad scope brings together critical knowledge from many disciplines, ranging from process technology to pharmacology to intellectual property issues. After introducing the overall early development workflow, the critical steps of early drug development are described in a sequential and enabling order: the availability of the drug substance and that of the drug product, the prediction of pharmacokinetics and -dynamics, as well as that of drug safety. The final section focuses on intellectual property aspects during early clinical development. The emphasis throughout is on recent case studies to exemplify salient points, resulting in an abundance of practice-oriented information that is usually not available from other sources. Aimed at medicinal chemists in industry as well as academia, this invaluable reference enables readers to understand and navigate the challenges in developing clinical candidate molecules that can be successfully used in phase one clinical trials.

Customer Reviews

No reviews or ratings yet - be the first to create one!

Product Details

General

Imprint

Wiley-VCH Verlag GmbH

Country of origin

Germany

Release date

August 2018

Availability

Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available.

Authors

Dimensions

262 x 174 x 46mm (L x W x T)

Format

Hardcover

Pages

816

ISBN-13

978-3-527-34149-8

Barcode

9783527341498

Categories

LSN

3-527-34149-8



Trending On Loot